
Keywords: Adh(VS), adamantane-acetyl-(6-aminohexanoyl)3-(leucinyl)3-vinyl-(methyl)-sulfone; BZ, bortezomib; ChTL, chymotrypsin-like; FT, filtrate; HSP, heat shock protein; IC50, concentration required to ablate 50% of activity; LC, lactacystin; PRSMS, mouse partial